Pharma & Biotech Growth Strategist

ABB; Ohio; On-site; USD 120,000 - 160,000; Full time

Job summary

ABB in the United States seeks a Strategic Segment Leader for Pharmaceutical & Biotechnology to drive growth, shape market strategy, and lead industry engagement.

You will develop ABB's growth strategy, build executive relationships with pharma manufacturers, biotech firms, CDMOs, EPCs, engineering firms, OEMs, and integrators, and coordinate opportunities across Electrification, Motion, and Automation. Travel 40-60% is expected.

Qualifications

• Bachelor's degree required; 10+ years relevant experience preferred.
• Minimum 5 years of business development or strategic sales experience.
• Experience in pharmaceutical, biotechnology, life sciences, or related markets.
• Knowledge of power distribution, automation, controls, or industrial infrastructure.
• Familiarity with cGMP, validation, cleanroom, and regulated manufacturing environments.
• Strong executive relationship and hunting skills.

Responsibilities

• Develop ABB's Pharmaceutical & Biotechnology growth strategy.
• Identify and qualify opportunities before RFQ issuance.
• Build executive relationships with pharmaceutical manufacturers, biotech firms, CDMOs, EPCs, engineering firms, OEMs, and integrators.
• Support thought leadership through industry events and associations.
• Monitor manufacturing, biologics, cell and gene therapy, and facility investment trends.
• Coordinate cross-business opportunities across Electrification, Motion, and Automation.
• Serve as Voice of the Market and provide sales enablement.

Skills

Executive relationship management

Strategic sales

Opportunity identification

Market intelligence

Sales enablement

Education

Bachelor's degree

Job description

ABB in the United States seeks a Strategic Segment Leader for Pharmaceutical & Biotechnology to drive growth, shape market strategy, and lead industry engagement.

You will develop ABB's growth strategy, build executive relationships with pharma manufacturers, biotech firms, CDMOs, EPCs, engineering firms, OEMs, and integrators, and coordinate opportunities across Electrification, Motion, and Automation. Travel 40-60% is expected.